PainReform Ltd- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 PainReform Ltd 公司

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

PainReform Ltd簡介



公司代碼PRFX

公司名稱PainReform Ltd

上市日期Sep 01, 2020

CEOHadar (Ilan)

員工數量2

證券類型Ordinary Share

年結日Sep 01

公司地址65 Yigal Alon St.

城市TEL AVIV-YAFO

上市交易所NASDAQ OMX - NASDAQ BASIC

國家Israel

郵編6744316

電話97237177051

網址https://painreform.com/

公司代碼PRFX

上市日期Sep 01, 2020

CEOHadar (Ilan)

PainReform Ltd公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Ilan Hadar

Chief Executive Officer, Chief Financial Officer

--

Dr. Eli Hazum

Chief Technology Officer, Director

--

Dr. Sigal Aviel

Chief Operating Officer

--

Mrs. Rita Keynan

Vice President - Pharmaceutical Operations

--

Dr. Ehud Geller, Ph.D.

Chairman of the Board

--

Mr. Efi Cohen-Arazi

Independent Director

--

Dr. Ellen S. Baron

Independent Director

--

Mr. Augustine J. (Gus) Lawlor

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Ilan Hadar

Chief Executive Officer, Chief Financial Officer

--

Dr. Eli Hazum

Chief Technology Officer, Director

--

Dr. Sigal Aviel

Chief Operating Officer

--

Mrs. Rita Keynan

Vice President - Pharmaceutical Operations

--

Dr. Ehud Geller, Ph.D.

Chairman of the Board

--

Mr. Efi Cohen-Arazi

Independent Director

--

收入明細

由於公司未披露，未能獲取相關數據

由於公司未披露，未能獲取相關數據

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

Bladeranger Ltd

4.57%

Two Sigma Investments, LP

0.41%

Medica Venture Partners

0.35%

L.I.A. Pure Capital Ltd

0.27%

UBS Financial Services, Inc.

0.11%

其他

94.29%

持股股東

佔比

Bladeranger Ltd

4.57%

Two Sigma Investments, LP

0.41%

Medica Venture Partners

0.35%

L.I.A. Pure Capital Ltd

0.27%

UBS Financial Services, Inc.

0.11%

其他

94.29%

股東類型

持股股東

佔比

Corporation

4.83%

Hedge Fund

0.41%

Private Equity

0.35%

Investment Advisor

0.12%

其他

94.29%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

15

6.89K

0.88%

-9.63K

2025Q3

15

20.01K

0.99%

-66.86K

2025Q2

22

221.75K

11.02%

-42.46K

2025Q1

21

208.02K

26.50%

+122.57K

2024Q4

19

72.04K

4.22%

+19.22K

2024Q3

16

43.23K

4.31%

+4.77K

2024Q2

16

35.44K

14.31%

+7.32K

2024Q1

15

25.67K

11.49%

-2.27K

2023Q4

17

26.00K

30.19%

+5.33K

2023Q3

18

17.50K

39.02%

-5.90K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Bladeranger Ltd

178.77K

4.57%

--

Apr 01, 2025

Two Sigma Investments, LP

16.19K

0.41%

+16.19K

--

Sep 30, 2025

Medica Venture Partners

13.72K

0.35%

+2.00

+0.01%

Apr 01, 2025

L.I.A. Pure Capital Ltd

10.42K

0.27%

+10.42K

--

Aug 28, 2024

UBS Financial Services, Inc.

19.00

0%

-6.07K

-99.69%

Sep 30, 2025

Osaic Holdings, Inc.

193.00

0%

--

Sep 30, 2025

SBI Securities Co., Ltd.

6.00

0%

--

Sep 30, 2025

Virtu Americas LLC

--

0%

-836.00

-100.00%

Sep 30, 2024

Geode Capital Management, L.L.C.

--

0%

-80.00

-100.00%

Oct 31, 2024

Citadel Advisors LLC

--

0%

-715.00

-100.00%

Jun 30, 2024

持股ETF



機構名稱

佔比

暫無數據

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

Feb 03, 2026

Merger

5→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Sep 05, 2024

Merger

6→1

公告日期

除權除息日

類型

比率

Feb 03, 2026

Merger

5→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Nov 19, 2024

Merger

4→1

Sep 05, 2024

Merger

6→1

Sep 05, 2024

Merger

6→1

Sep 05, 2024

Merger

6→1

Sep 05, 2024

Merger

6→1

Jun 30, 2023

Merger

10→1